Drugs that contain Nitisinone
1. List of Nityr drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10328029 | CYCLE PHARMS LTD | Pharmaceutical composition |
Jan, 2035
(11 years from now) | |
Market Authorisation Date: 26 July, 2017
Treatment: Treatment of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine
Dosage: TABLET;ORAL
NITYR family patents
2
United Kingdom
1
Canada
1
Slovenia
1
RS
1
Denmark
1
Portugal
1
Hungary
1
Spain
1
Poland
1
Croatia
1
United States
1
Lithuania
1
European Union
2. List of Orfadin drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9301932 | SWEDISH ORPHAN | Liquid pharmaceutical composition comprising nitisinone |
Feb, 2033
(9 years from now) | |
Market Authorisation Date: 22 April, 2016
Treatment: Treatment of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine
Dosage: SUSPENSION;ORAL
ORFADIN family patents
3
United States
2
Sweden
1
Australia
1
Israel
1
Croatia
1
Canada
1
New Zealand
1
Denmark
1
Spain
1
Chile
1
Cyprus
1
Ukraine
1
Russia
1
Poland
1
Japan
1
San Marino
1
Mexico
1
Slovenia
1
RS
1
China
1
Brazil
1
Hungary
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic